Overview

Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.
Phase:
Phase 1
Details
Lead Sponsor:
Forsight Vision4